United States Bioactive Substances Market Research Report Forecast 2017 to 2022
Delivery of the Report will take 2-3 working days once order is placed.
The United States Bioactive Substances Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Bioactive Substances industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bioactive Substances market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
BASF SE (Germany)
CP Kelco (US)
Cyanotech Corp. (US)
Nutrex Hawaii (US)
FMC Health and Nutrition (US)
NovaMatrix (Norway)
GlycoMar Ltd. (UK)
Jazz Pharmaceuticals plc (Ireland)
Lonza Group Ltd. (Switzerland)
United States Bioactive Substances Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Bioactive Substances Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
The United States Bioactive Substances Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Bioactive Substances industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bioactive Substances market study provides comprehensive data which enhances the understanding, scope and application of this report.
This report provides comprehensive analysis of
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
BASF SE (Germany)
CP Kelco (US)
Cyanotech Corp. (US)
Nutrex Hawaii (US)
FMC Health and Nutrition (US)
NovaMatrix (Norway)
GlycoMar Ltd. (UK)
Jazz Pharmaceuticals plc (Ireland)
Lonza Group Ltd. (Switzerland)
United States Bioactive Substances Market: Product Segment Analysis
Type 1
Type 2
Type 3
United States Bioactive Substances Market: Application Segment Analysis
Application 1
Application 2
Application 3
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
CHAPTER 1 BIOACTIVE SUBSTANCES MARKET OVERVIEW
1.1 Product Overview and Scope of Bioactive Substances
1.2 Bioactive Substances Market Segmentation by Type
1.2.1 United States Production Market Share of Bioactive Substances by Type in 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Bioactive Substances Market Segmentation by Application
1.3.1 Bioactive Substances Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bioactive Substances (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON BIOACTIVE SUBSTANCES INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES BIOACTIVE SUBSTANCES MARKET COMPETITION BY MANUFACTURERS
3.1 United States Bioactive Substances Production and Share by Manufacturers (2015 and 2016)
3.2 United States Bioactive Substances Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Bioactive Substances Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Bioactive Substances Manufacturing Base Distribution, Production Area and Product Type
3.5 Bioactive Substances Market Competitive Situation and Trends
3.5.1 Bioactive Substances Market Concentration Rate
3.5.2 Bioactive Substances Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES BIOACTIVE SUBSTANCES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Bioactive Substances Production and Market Share by Type (2012-2017)
4.2 United States Bioactive Substances Revenue and Market Share by Type (2012-2017)
4.3 United States Bioactive Substances Price by Type (2012-2017)
4.4 United States Bioactive Substances Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES BIOACTIVE SUBSTANCES MARKET ANALYSIS BY APPLICATION
5.1 United States Bioactive Substances Consumption and Market Share by Application (2012-2017)
5.2 United States Bioactive Substances Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES BIOACTIVE SUBSTANCES MANUFACTURERS ANALYSIS
6.1 BASF SE (Germany)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 CP Kelco (US)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Cyanotech Corp. (US)
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Nutrex Hawaii (US)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 FMC Health and Nutrition (US)
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 NovaMatrix (Norway)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 GlycoMar Ltd. (UK)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Jazz Pharmaceuticals plc (Ireland)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Lonza Group Ltd. (Switzerland)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 BIOACTIVE SUBSTANCES MANUFACTURING COST ANALYSIS
7.1 Bioactive Substances Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bioactive Substances
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Bioactive Substances Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bioactive Substances Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES BIOACTIVE SUBSTANCES MARKET FORECAST (2017-2022)
11.1 United States Bioactive Substances Production, Revenue Forecast (2017-2022)
11.2 United States Bioactive Substances Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Bioactive Substances Production Forecast by Type (2017-2022)
11.4 United States Bioactive Substances Consumption Forecast by Application (2017-2022)
11.5 Bioactive Substances Price Forecast (2017-2022)
CHAPTER 12 APPENDIX
1.1 Product Overview and Scope of Bioactive Substances
1.2 Bioactive Substances Market Segmentation by Type
1.2.1 United States Production Market Share of Bioactive Substances by Type in 2016
1.2.1 Type
1.2.2 Type
1.2.3 Type
1.3 Bioactive Substances Market Segmentation by Application
1.3.1 Bioactive Substances Consumption Market Share by Application in 2016
1.3.2 Application
1.3.3 Application
1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bioactive Substances (2011-2021)
CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON BIOACTIVE SUBSTANCES INDUSTRY
2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend
CHAPTER 3 UNITED STATES BIOACTIVE SUBSTANCES MARKET COMPETITION BY MANUFACTURERS
3.1 United States Bioactive Substances Production and Share by Manufacturers (2015 and 2016)
3.2 United States Bioactive Substances Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Bioactive Substances Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Bioactive Substances Manufacturing Base Distribution, Production Area and Product Type
3.5 Bioactive Substances Market Competitive Situation and Trends
3.5.1 Bioactive Substances Market Concentration Rate
3.5.2 Bioactive Substances Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
CHAPTER 4 UNITED STATES BIOACTIVE SUBSTANCES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 United States Bioactive Substances Production and Market Share by Type (2012-2017)
4.2 United States Bioactive Substances Revenue and Market Share by Type (2012-2017)
4.3 United States Bioactive Substances Price by Type (2012-2017)
4.4 United States Bioactive Substances Production Growth by Type (2012-2017)
CHAPTER 5 UNITED STATES BIOACTIVE SUBSTANCES MARKET ANALYSIS BY APPLICATION
5.1 United States Bioactive Substances Consumption and Market Share by Application (2012-2017)
5.2 United States Bioactive Substances Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
5.3.1 Potential Applications
5.3.2 Emerging Markets/Countries
CHAPTER 6 UNITED STATES BIOACTIVE SUBSTANCES MANUFACTURERS ANALYSIS
6.1 BASF SE (Germany)
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Product Type, Application and Specification
6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Business Overview
6.2 CP Kelco (US)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Product Type, Application and Specification
6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Business Overview
6.3 Cyanotech Corp. (US)
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Product Type, Application and Specification
6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Business Overview
6.4 Nutrex Hawaii (US)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Product Type, Application and Specification
6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Business Overview
6.5 FMC Health and Nutrition (US)
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Product Type, Application and Specification
6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Business Overview
6.6 NovaMatrix (Norway)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.7 GlycoMar Ltd. (UK)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Product Type, Application and Specification
6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Business Overview
6.8 Jazz Pharmaceuticals plc (Ireland)
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Product Type, Application and Specification
6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Business Overview
6.9 Lonza Group Ltd. (Switzerland)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Product Type, Application and Specification
6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Business Overview
CHAPTER 7 BIOACTIVE SUBSTANCES MANUFACTURING COST ANALYSIS
7.1 Bioactive Substances Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bioactive Substances
CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
8.1 Bioactive Substances Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bioactive Substances Major Manufacturers in 2016
8.4 Downstream Buyers
CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
CHAPTER 11 UNITED STATES BIOACTIVE SUBSTANCES MARKET FORECAST (2017-2022)
11.1 United States Bioactive Substances Production, Revenue Forecast (2017-2022)
11.2 United States Bioactive Substances Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Bioactive Substances Production Forecast by Type (2017-2022)
11.4 United States Bioactive Substances Consumption Forecast by Application (2017-2022)
11.5 Bioactive Substances Price Forecast (2017-2022)
CHAPTER 12 APPENDIX
LIST OF TABLES AND FIGURES
Figure Picture of Bioactive Substances
Table Classification of Bioactive Substances
Figure United States Sales Market Share of Bioactive Substances by Type in 2016
Table Application of Bioactive Substances
Figure United States Sales Market Share of Bioactive Substances by Application in 2016
Figure United States Bioactive Substances Sales and Growth Rate (2011-2021)
Figure United States Bioactive Substances Revenue and Growth Rate (2011-2021)
Table United States Bioactive Substances Sales of Key Manufacturers (2015 and 2016)
Table United States Bioactive Substances Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bioactive Substances Sales Share by Manufacturers
Figure 2016 Bioactive Substances Sales Share by Manufacturers
Table United States Bioactive Substances Revenue by Manufacturers (2015 and 2016)
Table United States Bioactive Substances Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bioactive Substances Revenue Share by Manufacturers
Table 2016 United States Bioactive Substances Revenue Share by Manufacturers
Table United States Market Bioactive Substances Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bioactive Substances Average Price of Key Manufacturers in 2015
Figure Bioactive Substances Market Share of Top 3 Manufacturers
Figure Bioactive Substances Market Share of Top 5 Manufacturers
Table United States Bioactive Substances Sales by Type (2012-2017)
Table United States Bioactive Substances Sales Share by Type (2012-2017)
Figure United States Bioactive Substances Sales Market Share by Type in 2015
Table United States Bioactive Substances Revenue and Market Share by Type (2012-2017)
Table United States Bioactive Substances Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bioactive Substances by Type (2012-2017)
Table United States Bioactive Substances Price by Type (2012-2017)
Figure United States Bioactive Substances Sales Growth Rate by Type (2012-2017)
Table United States Bioactive Substances Sales by Application (2012-2017)
Table United States Bioactive Substances Sales Market Share by Application (2012-2017)
Figure United States Bioactive Substances Sales Market Share by Application in 2016
Table United States Bioactive Substances Sales Growth Rate by Application (2012-2017)
Figure United States Bioactive Substances Sales Growth Rate by Application (2012-2017)
Table BASF SE (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BASF SE (Germany) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table BASF SE (Germany) Bioactive Substances Market Share (2012-2017)
Table CP Kelco (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Kelco (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table CP Kelco (US) Bioactive Substances Market Share (2012-2017)
Table Cyanotech Corp. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Cyanotech Corp. (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Cyanotech Corp. (US) Bioactive Substances Market Share (2012-2017)
Table Nutrex Hawaii (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Nutrex Hawaii (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Nutrex Hawaii (US) Bioactive Substances Market Share (2012-2017)
Table FMC Health and Nutrition (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table FMC Health and Nutrition (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table FMC Health and Nutrition (US) Bioactive Substances Market Share (2012-2017)
Table NovaMatrix (Norway) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table NovaMatrix (Norway) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table NovaMatrix (Norway) Bioactive Substances Market Share (2012-2017)
Table GlycoMar Ltd. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlycoMar Ltd. (UK) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table GlycoMar Ltd. (UK) Bioactive Substances Market Share (2012-2017)
Table Jazz Pharmaceuticals plc (Ireland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Market Share (2012-2017)
Table Lonza Group Ltd. (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioactive Substances
Figure Manufacturing Process Analysis of Bioactive Substances
Figure Bioactive Substances Industrial Chain Analysis
Table Raw Materials Sources of Bioactive Substances Major Manufacturers in 2016
Table Major Buyers of Bioactive Substances
Table Distributors/Traders List
Figure United States Bioactive Substances Production and Growth Rate Forecast (2017-2022)
Figure United States Bioactive Substances Revenue and Growth Rate Forecast (2017-2022)
Table United States Bioactive Substances Production Forecast by Type (2017-2022)
Table United States Bioactive Substances Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
BASF SE (Germany)
CP Kelco (US)
Cyanotech Corp. (US)
Nutrex Hawaii (US)
FMC Health and Nutrition (US)
NovaMatrix (Norway)
GlycoMar Ltd. (UK)
Jazz Pharmaceuticals plc (Ireland)
Lonza Group Ltd. (Switzerland)
Marinova Pty Ltd (Australia)
New England Biolabs Inc (US)
oceanBASIS GmbH (Germany)
PharmaMar S.A (Spain)
PML Applications Ltd. (UK)
Prolume Ltd (US)
BioLume(r), Inc. (US)
Royal DSM N.V (Netherlands)
Figure Picture of Bioactive Substances
Table Classification of Bioactive Substances
Figure United States Sales Market Share of Bioactive Substances by Type in 2016
Table Application of Bioactive Substances
Figure United States Sales Market Share of Bioactive Substances by Application in 2016
Figure United States Bioactive Substances Sales and Growth Rate (2011-2021)
Figure United States Bioactive Substances Revenue and Growth Rate (2011-2021)
Table United States Bioactive Substances Sales of Key Manufacturers (2015 and 2016)
Table United States Bioactive Substances Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bioactive Substances Sales Share by Manufacturers
Figure 2016 Bioactive Substances Sales Share by Manufacturers
Table United States Bioactive Substances Revenue by Manufacturers (2015 and 2016)
Table United States Bioactive Substances Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bioactive Substances Revenue Share by Manufacturers
Table 2016 United States Bioactive Substances Revenue Share by Manufacturers
Table United States Market Bioactive Substances Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bioactive Substances Average Price of Key Manufacturers in 2015
Figure Bioactive Substances Market Share of Top 3 Manufacturers
Figure Bioactive Substances Market Share of Top 5 Manufacturers
Table United States Bioactive Substances Sales by Type (2012-2017)
Table United States Bioactive Substances Sales Share by Type (2012-2017)
Figure United States Bioactive Substances Sales Market Share by Type in 2015
Table United States Bioactive Substances Revenue and Market Share by Type (2012-2017)
Table United States Bioactive Substances Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bioactive Substances by Type (2012-2017)
Table United States Bioactive Substances Price by Type (2012-2017)
Figure United States Bioactive Substances Sales Growth Rate by Type (2012-2017)
Table United States Bioactive Substances Sales by Application (2012-2017)
Table United States Bioactive Substances Sales Market Share by Application (2012-2017)
Figure United States Bioactive Substances Sales Market Share by Application in 2016
Table United States Bioactive Substances Sales Growth Rate by Application (2012-2017)
Figure United States Bioactive Substances Sales Growth Rate by Application (2012-2017)
Table BASF SE (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BASF SE (Germany) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table BASF SE (Germany) Bioactive Substances Market Share (2012-2017)
Table CP Kelco (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table CP Kelco (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table CP Kelco (US) Bioactive Substances Market Share (2012-2017)
Table Cyanotech Corp. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Cyanotech Corp. (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Cyanotech Corp. (US) Bioactive Substances Market Share (2012-2017)
Table Nutrex Hawaii (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Nutrex Hawaii (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Nutrex Hawaii (US) Bioactive Substances Market Share (2012-2017)
Table FMC Health and Nutrition (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table FMC Health and Nutrition (US) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table FMC Health and Nutrition (US) Bioactive Substances Market Share (2012-2017)
Table NovaMatrix (Norway) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table NovaMatrix (Norway) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table NovaMatrix (Norway) Bioactive Substances Market Share (2012-2017)
Table GlycoMar Ltd. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlycoMar Ltd. (UK) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table GlycoMar Ltd. (UK) Bioactive Substances Market Share (2012-2017)
Table Jazz Pharmaceuticals plc (Ireland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Market Share (2012-2017)
Table Lonza Group Ltd. (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Production, Revenue, Price and Gross Margin (2012-2017)
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioactive Substances
Figure Manufacturing Process Analysis of Bioactive Substances
Figure Bioactive Substances Industrial Chain Analysis
Table Raw Materials Sources of Bioactive Substances Major Manufacturers in 2016
Table Major Buyers of Bioactive Substances
Table Distributors/Traders List
Figure United States Bioactive Substances Production and Growth Rate Forecast (2017-2022)
Figure United States Bioactive Substances Revenue and Growth Rate Forecast (2017-2022)
Table United States Bioactive Substances Production Forecast by Type (2017-2022)
Table United States Bioactive Substances Consumption Forecast by Application (2017-2022)
COMPANIES MENTIONED
BASF SE (Germany)
CP Kelco (US)
Cyanotech Corp. (US)
Nutrex Hawaii (US)
FMC Health and Nutrition (US)
NovaMatrix (Norway)
GlycoMar Ltd. (UK)
Jazz Pharmaceuticals plc (Ireland)
Lonza Group Ltd. (Switzerland)
Marinova Pty Ltd (Australia)
New England Biolabs Inc (US)
oceanBASIS GmbH (Germany)
PharmaMar S.A (Spain)
PML Applications Ltd. (UK)
Prolume Ltd (US)
BioLume(r), Inc. (US)
Royal DSM N.V (Netherlands)
